Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by CCR7 is a member of the G protein-coupled receptor family. Additionally we are shipping CCR7 Kits (25) and CCR7 Proteins (5) and many more products for this protein.
Showing 10 out of 214 products:
Human Polyclonal CCR7 Primary Antibody for EIA, IHC (fro) - ABIN492856
Tran, Miller: Chemokine receptors: signposts to brain development and disease. in Nature reviews. Neuroscience 2003
Show all 5 references for ABIN492856
Human Polyclonal CCR7 Primary Antibody for WB - ABIN871692
Birkenbach, Josefsen, Yalamanchili, Lenoir, Kieff: Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. in Journal of virology 1993
Human Polyclonal CCR7 Primary Antibody for IF, ELISA - ABIN1535569
Schweickart, Raport, Godiska, Byers, Eddy, Shows, Gray: Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2. in Genomics 1995
Human Polyclonal CCR7 Primary Antibody for IF (p), IHC (p) - ABIN674724
Ge, Li, Jiang, You, Liu, Zhong, Huang, Xing: Integration of nondegradable polystyrene and degradable gelatin in a core-sheath nanofibrous patch for pelvic reconstruction. in International journal of nanomedicine 2015
Human Polyclonal CCR7 Primary Antibody for FACS, WB - ABIN1742100
Sánchez-Sánchez, Riol-Blanco, Rodríguez-Fernández: The multiple personalities of the chemokine receptor CCR7 in dendritic cells. in Journal of immunology (Baltimore, Md. : 1950) 2006
Human Polyclonal CCR7 Primary Antibody for FACS, IF - ABIN651190
Berndt, Haverkampf, Reith, Keil, Niggemann, Zänker, Dittmar: Fusion of CCL21 Non-Migratory Active Breast Epithelial and Breast Cancer Cells Give Rise to CCL21 Migratory Active Tumor Hybrid Cell Lines. in PLoS ONE 2013
Human Monoclonal CCR7 Primary Antibody for FACS - ABIN1105995
Zanin-Zhorov, Hershkoviz, Hecht, Cahalon, Lider: Fibronectin-associated Fas ligand rapidly induces opposing and time-dependent effects on the activation and apoptosis of T cells. in Journal of immunology (Baltimore, Md. : 1950) 2003
Ccr7 functions during axis formation as a GPCR (show GPRC6A Antibodies) to inhibit beta-catenin (show CTNNB1 Antibodies), likely by promoting Ca(2 (show CA2 Antibodies)+) transients throughout the blastula.
data reveal that CCR7 plays multifaceted roles in regulating collecting vessel permeability and fibrosis, with one of the key players being IRF4 (show IRF4 Antibodies)-dependent DCs.
the graft site microenvironment plays a critical role in alloimmunity by determining DC trafficking through the CCR7-CCL19 (show CCL19 Antibodies)/21 axis.
Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta (show CD247 Antibodies)) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice
CD11b (show ITGAM Antibodies) and CXCR4 (show CXCR4 Antibodies) but not CCR7 have roles in neutrophil migration modulating lymph node lymphocyte proliferation in bacterial infections
The results highlight a novel role of CCR7 in regulating effector CD8 (show CD8A Antibodies) T cell migration in the spleen and demonstrate differential requirement of CCR7 for primary and secondary CD8 (show CD8A Antibodies) T cell responses to infection.
mucosal draining lymph nodes express CCR7, which has a role in trafficking of RORgamma innate lymphoid cells
results demonstrate a contribution of CCR7 to STAP-2 (show STAP2 Antibodies)-dependent enhancement of BCR-ABL (show ABL1 Antibodies)-mediated cell growth in Ba/F3 cells
CCR7 increases the secretion of nitric oxide and modulates the T cell immune response.
Results suggest that Mfn2 (show MFN2 Antibodies) and OPA1 (show MED12 Antibodies) are upregulated during bone marrow progenitor differentiation and promote the migration of immature dendritic cells by regulating the expression of CCR7.
CCR7 regulates the intestinal TH1 (show HAND1 Antibodies)/TH17/Treg balance during Crohn's-like murine ileitis.
Our findings suggested that MUC1 (show MUC1 Antibodies) plays an important role in CCL21 (show CCL21 Antibodies)-CCR7-induced lymphatic metastasis and may serve as a therapeutic target in esophageal squamous cell carcinoma .
Membrane associated PGES1dependent release of PGE2 is ccompanied by elevated CCR7 expression in colon cancer cells.
Pyk2 (show PTK2B Antibodies) is a key downstream signaling molecules of CCR7 in SCCHN, which promotes SCCHN tumorigenesis and progression.
the CCR7 axis mediates TGF-beta1 (show TGFB1 Antibodies)-induced EMT (show ITK Antibodies) via crosstalk with NF-kappaB (show NFKB1 Antibodies) signaling, facilitating lymph node metastasis and poorer overall survival in patients with gastric cancer
Blockade of CCR7, or treatment with a p38 MAP kinase (show MAPK14 Antibodies) inhibitor, reduced lymphatic dissemination of epithelial-mesenchymal transition cells.
findings indicated that circulating memory Tfh cells, especially CCR7+ICOS (show CTLA4 Antibodies)+ memory Tfh cells, may be associated with the relapse of MS and may serve as a new therapeutic target
The chemotactic interaction between CCR7 and its ligand, CCL21 (show CCL21 Antibodies), may be a critical event during progression in pancreatic cancer
CrkL (show CRKL Antibodies) regulates CCL19 (show CCL19 Antibodies) and CCR7-induced epithelial-to-mesenchymal transition via ERK (show EPHB2 Antibodies) signaling pathway in epithelial ovarian carcinoma patients.
Recycling accounts, to a major extent, for the high levels of surface CXCR4 (show CXCR4 Antibodies)/CCR7 on CLL cells. Increased CCR4 (show CCR4 Antibodies)/CCR7 is detectable not only in circulating leukemic cells, but also in secondary lymphoid organs of CLL patients with lymphoadenopathy.
in given donor/recipient pairs, KIR2DS4 (show KIR2DS4 Antibodies) expression may contribute to potentiating natural killer cell function by increasing both the cytotoxicity and the expression of CCR7 on their surface.
Fluorescent dye-labeled gammadelta T cells from afferent and efferent lymph lack CCR7 surface expression and display high levels of CD62L (show SELL Antibodies) compared with CD4 (show CD4 Antibodies) T cells, which do express CCR7.
CCR7 transcripts were minimally expressed in ex vivo and proliferating WC1(+)gammadelta T cells, a unique cell population with proinflammatory characteristics
the pattern of expression of CCR7 in different populations of porcine lymphocytes appears to be similar to that of human, highlighting the value of the pig as a useful animal model for biomedical studies.
Pre-translntation of sertli cell CCR7 significantly suppresses lymphocyte proliferation and prolongs allogeneic skin graft survival.
The protein encoded by this gene is a member of the G protein-coupled receptor family. This receptor was identified as a gene induced by the Epstein-Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. This receptor is expressed in various lymphoid tissues and activates B and T lymphocytes. It has been shown to control the migration of memory T cells to inflamed tissues, as well as stimulate dendritic cell maturation. The chemokine (C-C motif) ligand 19 (CCL19/ECL) has been reported to be a specific ligand of this receptor.
C-C chemokine receptor type 7
, CC chemokine receptor 7
, chemokine (C-C motif) receptor 7 a
, chemokine (C-C motif) receptor 7
, c-C chemokine receptor type 7-like
, C-C CKR-7
, EBV-induced G-protein coupled receptor 1
, MIP-3 beta receptor
, chemokine (C-C) receptor 7
, epstein-Barr virus-induced G-protein coupled receptor 1
, EBV-induced G protein-coupled receptor 1
, Epstein-Barr virus induced G-protein coupled receptor
, Epstein-Barr virus induced gene 1
, lymphocyte-specific G protein-coupled peptide receptor
, chemokine receptor 7